Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL(3)B

BACKGROUND: The high rate of mortality due to malaria and the worldwide distribution of parasite resistance to the commonly used antimalarial drugs chloroquine and pyrimethamine emphasize the urgent need for the development of new antimalarial drugs. An alternative approach to the long and uncertain...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Reynolds, Jennifer M, El Bissati, Kamal, Brandenburg, Jens, Günzl, Arthur, Mamoun, Choukri Ben
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2007
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2213633/
https://ncbi.nlm.nih.gov/pubmed/17956613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-7-13
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg